Sevion Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sevion Therapeutics, Inc.
CIK #0001035354
EDGAR Form CIK 2011 - 2025
10-K [0001035354]
10-Q [0001035354]
3 [0001035354]
4 [0001035354]
8-K [0001035354]
D [0001035354]
SC 13D [0001035354]
SC 13G [0001035354]
Form 13D/13G Filer Form 13D/13G Subject Filed
Gurnet Point LP Eloxx Pharmaceuticals Inc [2021-06-29]
Roche Finance Ltd Eloxx Pharmaceuticals Inc [2021-06-14]
Advent Life Sciences LLP Eloxx Pharmaceuticals Inc [2021-04-13]
OPKO Health Inc Eloxx Pharmaceuticals Inc [2019-05-09]
Alpha Capital Anstalt Eloxx Pharmaceuticals Inc [2018-07-26]
Menora Mivtachim Holdings Ltd Eloxx Pharmaceuticals Inc [2018-05-29]
Pontifax Management 4 GP 2015 Ltd Eloxx Pharmaceuticals Inc [2018-01-02]
LSP V Cooperatieve UA Eloxx Pharmaceuticals Inc [2017-12-29]
Catalyst CEL Management Ltd Eloxx Pharmaceuticals Inc [2017-12-29]
Technion Research & Development Foundation Ltd Eloxx Pharmaceuticals Inc [2017-12-29]
GHS Partners Ltd Eloxx Pharmaceuticals Inc [2017-12-29]
Pontifax Management III GP 2011 Ltd Eloxx Pharmaceuticals Inc [2017-12-29]
Shabtai Gilad Eloxx Pharmaceuticals Inc [2017-12-29]
OPKO Health Inc Sevion Therapeutics Inc [2017-08-04]
Brauser Michael Sevion Therapeutics Inc [2015-03-20]
Smider Vaughn Senesco Technologies Inc [2014-05-29]
Frost Phillip MD ET AL Senesco Technologies Inc [2014-05-29]
Frost Gamma Investments Trust Senesco Technologies Inc [2013-12-19]
Brauser Michael Senesco Technologies Inc [2013-12-19]
Alpha Capital Anstalt Senesco Technologies Inc [2013-12-16]
Honig Barry C Senesco Technologies Inc [2013-10-08]
Brauser Michael Senesco Technologies Inc [2013-10-04]
Alpha Capital Anstalt Senesco Technologies Inc [2013-05-10]
Denville & Dover Fund LLC Senesco Technologies Inc [2013-01-29]
[2012-03-19]
Form 3/4/5 Subject 2011 - 2025
Eloxx Pharmaceuticals, Inc.
Walts Alan Edmund
Aggarwal Sumit
Rubin Steven D
Androski Lindsay
Kariv Tomer
Modur Vijay
Avnur Zafrira
Veinrib Gadi
Seehra Jasbir
View All
Terms | Privacy | Guide
tony@aum13f.com